Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng Shen

Showing results (421-430 of 515) with videos related to

Pageof 52
Sort By:
Cancer Letters|December 30, 2024
Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53/E2F1/FOXM1-axisYunlu Jia, Yongxia Chen, Ming Chen, et al.
Cancer & Metabolism|December 6, 2022
Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancerYao Shen, Pan Zhao, Kewei Dong, et al.
Nature Communications|June 6, 2022
Towards n-type conductivity in hexagonal boron nitrideShiqiang Lu, Peng Shen, Hongye Zhang, et al.
Frontiers in Endocrinology|September 11, 2025
Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular diseaseLijia Liu, Haiqing Zhang, Xiaowei Chen, et al.
Yi Chuan = Hereditas|April 20, 2023
Study on detection of CNVs using human whole genome bisulfite sequencing dataDan-Tong Xu, Yi-Fei Wang, Jia-Li Cai, et al.
Anti-Cancer Drugs|April 7, 2007
Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancerChen X Zhang, Sui Huang, Nong Xu, et al.
Experimental and Therapeutic Medicine|June 5, 2023
Pachymic acid modulates sirtuin 6 activity to alleviate lipid metabolism disordersZhi-Sen Pan, Yan-Ling Chen, Kai-Jia Tang, et al.
British Journal of Cancer|October 22, 2019
YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathwaysQun Chen, Chuang Yang, Lei Chen, et al.
International Journal of Epidemiology|February 24, 2025
Development of chronic obstructive pulmonary disease after a tuberculosis episode in a large, population-based cohort from Eastern ChinaJianbing Wang, Luhua Yu, Zongming Yang, et al.
Molecular Cancer|June 1, 2022
CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2Lingdong Meng, Yihan Zhang, Pengfei Wu, et al.
Pageof 52

Showing results (421-430 of 515) with videos related to

Sort By:
Pageof 52
Cancer Letters|December 30, 2024
Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53/E2F1/FOXM1-axisYunlu Jia, Yongxia Chen, Ming Chen, et al.
Cancer & Metabolism|December 6, 2022
Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancerYao Shen, Pan Zhao, Kewei Dong, et al.
Nature Communications|June 6, 2022
Towards n-type conductivity in hexagonal boron nitrideShiqiang Lu, Peng Shen, Hongye Zhang, et al.
Frontiers in Endocrinology|September 11, 2025
Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular diseaseLijia Liu, Haiqing Zhang, Xiaowei Chen, et al.
Yi Chuan = Hereditas|April 20, 2023
Study on detection of CNVs using human whole genome bisulfite sequencing dataDan-Tong Xu, Yi-Fei Wang, Jia-Li Cai, et al.
Anti-Cancer Drugs|April 7, 2007
Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancerChen X Zhang, Sui Huang, Nong Xu, et al.
Experimental and Therapeutic Medicine|June 5, 2023
Pachymic acid modulates sirtuin 6 activity to alleviate lipid metabolism disordersZhi-Sen Pan, Yan-Ling Chen, Kai-Jia Tang, et al.
British Journal of Cancer|October 22, 2019
YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathwaysQun Chen, Chuang Yang, Lei Chen, et al.
International Journal of Epidemiology|February 24, 2025
Development of chronic obstructive pulmonary disease after a tuberculosis episode in a large, population-based cohort from Eastern ChinaJianbing Wang, Luhua Yu, Zongming Yang, et al.
Molecular Cancer|June 1, 2022
CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2Lingdong Meng, Yihan Zhang, Pengfei Wu, et al.
Pageof 52